These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2115590)

  • 1. Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways diseases.
    Tredgett MW; Doherty C; Govan JR
    J Med Microbiol; 1990 Jul; 32(3):169-72. PubMed ID: 2115590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M; Thomas J; Diggle SP
    mBio; 2021 May; 12(3):. PubMed ID: 33947755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecology of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Horrevorts AM; Borst J; Puyk RJ; De Ridder R; Dzoljicdanilovic G; Degener JE; Kerrebijn KF; Michel MF
    J Med Microbiol; 1990 Feb; 31(2):119-24. PubMed ID: 2106033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition in Biofilms between Cystic Fibrosis Isolates of
    Oluyombo O; Penfold CN; Diggle SP
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.
    Valderrey AD; Pozuelo MJ; Jiménez PA; Maciá MD; Oliver A; Rotger R
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):20-7. PubMed ID: 20727465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Spencker FB; Haupt S; Claros MC; Walter S; Lietz T; Schille R; Rodloff AC
    Clin Microbiol Infect; 2000 Nov; 6(11):600-7. PubMed ID: 11168063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyocin typing of Pseudomonas aeruginosa isolates from children with cystic fibrosis.
    Richardson CJ; Burke V; Bailey M; Fisher A
    Pathology; 1991 Jul; 23(3):229-32. PubMed ID: 1780188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pyocin typing of Pseudomonas aeruginosa strains].
    Moroz AF; Petropavlovskaia IS; Osokina TI; Frolova VV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):31-5. PubMed ID: 6422681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriocin-mediated competition in cystic fibrosis lung infections.
    Ghoul M; West SA; Johansen HK; Molin S; Harrison OB; Maiden MC; Jelsbak L; Bruce JB; Griffin AS
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26311664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Römling U; Fiedler B; Bosshammer J; Grothues D; Greipel J; von der Hardt H; Tümmler B
    J Infect Dis; 1994 Dec; 170(6):1616-21. PubMed ID: 7996008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of lipopolysaccharide mutants and R2-pyocin susceptible variants in
    Mei M; Pheng P; Kurzeja-Edwards D; Diggle SP
    Microbiol Spectr; 2023 Dec; 11(6):e0177323. PubMed ID: 37877708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pseudomonas pyocin typing method applicable to the clinical laboratory.
    Barnes WG; Gitta PS
    Am J Med Technol; 1979 Aug; 45(8):688-91. PubMed ID: 114048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis.
    Boukadida J; De Montalembert M; Lenoir G; Scheinmann P; Véron M; Berche P
    J Med Microbiol; 1993 Jan; 38(1):29-33. PubMed ID: 8418289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.
    Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B
    Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Petersen US; Høiby N
    APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients.
    Redero M; López-Causapé C; Aznar J; Oliver A; Blázquez J; Prieto AI
    J Antimicrob Chemother; 2018 Oct; 73(10):2770-2776. PubMed ID: 30052973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does pseudomonas cross-infection occur between cystic-fibrosis patients.
    Kelly NM; Fitzgerald MX; Tempany E; O'Boyle C; Falkiner FR; Keane CT
    Lancet; 1982 Sep; 2(8300):688-90. PubMed ID: 6126629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.